110 related articles for article (PubMed ID: 7183891)
21. Biochemical procedures as aids in diagnosis of different forms of cancer.
Schwartz MK
Ann Clin Lab Sci; 1974; 4(2):95-103. PubMed ID: 4150613
[No Abstract] [Full Text] [Related]
22. Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9.
Grimes R; Reddy SV; Leach RJ; Scarcez T; Roodman GD; Sakaguchi AY; Lalley PA; Windle JJ
Genomics; 1993 Feb; 15(2):421-2. PubMed ID: 8449511
[TBL] [Abstract][Full Text] [Related]
23. A case of premenopausal breast cancer showing remarkable elevation of serum alkaline phosphatase level during treatment with LH-RH analog.
Ito K; Komatsu A; Kanai T; Koyama H; Hama Y; Shingu K; Fujimori M; Amano J
Breast J; 2005; 11(6):523-4. PubMed ID: 16297128
[No Abstract] [Full Text] [Related]
24. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
25. Effects of the (1-34) fragment of synthetic parathyroid hormone-related protein on tartrate-resistant acid phosphatase and alkaline phosphatase and alkaline phosphatase activities, and on osteocalcin synthesis, in cultured fetal rat calvaria.
Torres R; de la Piedra C; Rapado A
Miner Electrolyte Metab; 1993; 19(2):64-70. PubMed ID: 8377726
[TBL] [Abstract][Full Text] [Related]
26. [Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)].
Opri F; Kirchner H
Zentralbl Gynakol; 1981; 103(10):564-8. PubMed ID: 7269869
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte alkaline phosphatase and serum alkaline phosphatase in patients with metastatic breast and colon cancer.
Walach N; Gur Y
Neoplasma; 1996; 43(5):297-300. PubMed ID: 8996547
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
Withold W
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):785-99. PubMed ID: 8933101
[TBL] [Abstract][Full Text] [Related]
29. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
30. [The biochemical markers of bone remodeling in cancer patients with skeletal involvement].
Liubimova NV; Bronnikov IIu; Robins SP; Trapeznikova MF; Kushlinskiĭ NE
Vopr Onkol; 2000; 46(3):290-7. PubMed ID: 10976274
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis of occult skeletal metastasis: alkaline phosphatase versus skeletal scintigraphy].
Zieger M
Med Klin Prax; 1982 May; 77(11):44-50. PubMed ID: 7099105
[TBL] [Abstract][Full Text] [Related]
32. Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis.
Rico H; Revilla M; Arnanz F; Villa LF; Perera S; Arribas I
Obstet Gynecol; 1993 Feb; 81(2):272-5. PubMed ID: 8423962
[TBL] [Abstract][Full Text] [Related]
33. Enzyme immunoassay for tartrate-resistant acid phosphatase.
Lam KW; Siemens M; Sun T; Li CY; Yam LT
Clin Chem; 1982 Mar; 28(3):467-70. PubMed ID: 7039869
[TBL] [Abstract][Full Text] [Related]
34. Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease.
Lam KW; Desnick RJ
Prog Clin Biol Res; 1982; 95():267-78. PubMed ID: 6750653
[No Abstract] [Full Text] [Related]
35. Total, tartrate-resistant, and tartrate-inhibited acid phosphatases in serum: biological variations and reference limits.
Schiele F; Artur Y; Floc'h AY; Siest G
Clin Chem; 1988 Apr; 34(4):685-90. PubMed ID: 3359601
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of biochemical findings of the blood in bone tumors].
Imura S; Morita S; Hayashi N; Azuchi T; Matsumoto H
Seikei Geka; 1966 Nov; 17(12):983-9. PubMed ID: 6009808
[No Abstract] [Full Text] [Related]
37. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of tartrate-resistant acid phosphatase activity in lymphoma cells of the bone marrow].
Mariańska B; Maj S; Apel D
Acta Haematol Pol; 1985; 16(3-4):122-6. PubMed ID: 3835768
[No Abstract] [Full Text] [Related]
39. [Total and tartrate-inhibited acid phosphatases in serum. Significance of rectal examination in normal individuals and patients with benign prostatic hypertrophy].
Nielsen ML; Christensen P; Antoni E
Ugeskr Laeger; 1971 Nov; 133(46):2279-84. PubMed ID: 4109415
[No Abstract] [Full Text] [Related]
40. The detection of skeletal metastases from carcinoma of the breast.
Galasko CS
Surg Gynecol Obstet; 1971 Jun; 132(6):1019-24. PubMed ID: 5578424
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
